CytomX Aktie
3,17
EUR
-0,09
EUR
-2,79
%
3,74
USD
-0,14
USD
-3,48
%
Werbung
CytomX Aktie Analyse
| 14.05.19 | CytomX Overweight | Cantor Fitzgerald | |
| 11.03.19 | CytomX overweight | Barclays Capital | |
| 13.09.18 | CytomX Buy | H.C. Wainwright & Co. | |
| 08.09.17 | CytomX Outperform | Wedbush Morgan Securities Inc. | |
| 27.03.17 | CytomX Buy | H.C. Wainwright & Co. | |
| 02.03.17 | CytomX Buy | Instinet | |
| 02.11.15 | CytomX Outperform | Oppenheimer & Co. Inc. |
Werbung
Werbung